Pages that link to "Q415259"
Jump to navigation
Jump to search
The following pages link to terbinafine (Q415259):
Displayed 50 items.
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- (RS)-metoprolol (Q409468) (← links)
- fungal infectious disease (Q464067) (← links)
- tinea corporis (Q775927) (← links)
- onychomycosis (Q917620) (← links)
- pityriasis versicolor (Q926462) (← links)
- dermatomycosis (Q3705876) (← links)
- tinea pedis (Q5609817) (← links)
- tinea (Q17141201) (← links)
- Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents (Q24676192) (← links)
- Molecular mechanism of terbinafine resistance in Saccharomyces cerevisiae (Q27939054) (← links)
- Terbinafine: mode of action and properties of the squalene epoxidase inhibition (Q28284524) (← links)
- Treatment of Candida nail infection with terbinafine (Q28299342) (← links)
- Interaction of terbinafine with human serum and serum proteins (Q28342799) (← links)
- Use of terbinafine in mouse and rat models of Pneumocystis carinii pneumonia (Q28345184) (← links)
- Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects (Q28347094) (← links)
- Antifungal activity of the allylamine derivative terbinafine in vitro (Q28361964) (← links)
- In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B (Q28365213) (← links)
- Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis (Q28368092) (← links)
- Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes (Q28368768) (← links)
- Terbinafine. An update of its use in superficial mycoses (Q28370491) (← links)
- In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts (Q28379512) (← links)
- Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine (Q28551102) (← links)
- In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride (Q28833579) (← links)
- Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison (Q30472094) (← links)
- Single crystal structure, solid state characterization and dissolution rate of terbinafine hydrochloride. (Q30597220) (← links)
- Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus (Q30764085) (← links)
- Determination of terbinafine in tissues (Q30881715) (← links)
- Comparative bioavailability of two formulations of terbinafine. Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers. (Q30978997) (← links)
- Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study (Q31031111) (← links)
- Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil). (Q31047502) (← links)
- Terbinafine resistance mediated by salicylate 1-monooxygenase in Aspergillus nidulans. (Q31108109) (← links)
- An evaluation of the in vitro activity of terbinafine (Q31380220) (← links)
- Terbinafine 1% cream vs. bifonazole 1% cream in the treatment of tinea cruris (Q31946764) (← links)
- Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly (Q32035764) (← links)
- Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. (Q32035783) (← links)
- Determination of terbinafine hydrochloride in cat hair by two chromatographic methods (Q32049386) (← links)
- Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis (Q33182416) (← links)
- The successful treatment of Trichophyton rubrum nail bed (distal subungual) onychomycosis with intermittent pulse-dosed terbinafine (Q33204108) (← links)
- Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine (Q33206055) (← links)
- [Colestasic toxic hepatitis caused by terbinafine: case report]. (Q33210270) (← links)
- An improved high-throughput liquid chromatographic/tandem mass spectrometric method for terbinafine quantification in human plasma, using automated liquid-liquid extraction based on 96-well format plates (Q33269117) (← links)
- Transcriptional profiles of response to terbinafine in Trichophyton rubrum (Q33411340) (← links)
- Successful treatment of severe kerion Celsi in an immunocompromised girl with evacuation of pus, terbinafine and short course glucocorticosteroids (Q33429824) (← links)
- The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis (Q33537004) (← links)
- Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and terbinafine treatment: a case report and review of the literature (Q33564554) (← links)
- Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections (Q33569526) (← links)
- Effect of terbinafine on theophylline pharmacokinetics in healthy volunteers (Q33691559) (← links)
- Drug interactions with itraconazole, fluconazole, and terbinafine and their management (Q33699931) (← links)
- Rational design for variability minimization in bioanalytical method validation: illustration with LC-MS/MS assay method for terbinafine estimation in human plasma (Q33720929) (← links)